Stockscreener 앱 받기
21.40
0.70%
-0.15
시간 외 거래:
21.41
0.01
+0.05%
전일 마감가:
$21.55
열려 있는:
$21.53
하루 거래량:
437.80K
Relative Volume:
0.64
시가총액:
$1.11B
수익:
$412.82M
순이익/손실:
$-8.19M
주가수익비율:
-138.87
EPS:
-0.1541
순현금흐름:
$64.17M
1주 성능:
+3.38%
1개월 성능:
+33.33%
6개월 성능:
+31.21%
1년 성능:
+30.81%
1일 변동 폭
$21.12
$22.06
1주일 범위
$20.53
$22.30
52주 변동 폭
$10.96
$23.24
Caredx Inc Stock (CDNA) Company Profile
명칭
Caredx Inc
전화
415-287-2300
주소
8000 MARINA BLVD, BRISBANE, CA
Compare CDNA vs TMO, DHR, IDXX, WAT, A
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
21.40 | 1.11B | 412.82M | -8.19M | 64.17M | -0.1541 |
TMO
Thermo Fisher Scientific Inc
|
459.30 | 168.20B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
166.26 | 117.86B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
533.92 | 41.97B | 4.45B | 1.10B | 1.06B | 13.59 |
WAT
Waters Corp
|
352.21 | 34.17B | 3.77B | 449.25M | 240.68M | 7.8556 |
A
Agilent Technologies Inc
|
112.90 | 31.50B | 7.07B | 1.29B | 993.00M | 4.5355 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-06 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2025-08-26 | 개시 | William Blair | Mkt Perform |
| 2025-01-15 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2024-08-28 | 개시 | Wells Fargo | Underweight |
| 2024-08-19 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2024-05-13 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2024-05-01 | 업그레이드 | Craig Hallum | Hold → Buy |
| 2023-11-09 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2023-08-15 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-05-11 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-03-07 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2023-03-03 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2023-03-03 | 다운그레이드 | Raymond James | Strong Buy → Mkt Perform |
| 2022-04-25 | 개시 | Stephens | Overweight |
| 2021-07-20 | 재개 | BTIG Research | Buy |
| 2021-06-03 | 개시 | Goldman | Buy |
| 2021-02-26 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2020-10-30 | 재확인 | H.C. Wainwright | Buy |
| 2020-10-08 | 재확인 | H.C. Wainwright | Buy |
| 2020-10-02 | 재확인 | H.C. Wainwright | Buy |
| 2020-08-05 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-26 | 개시 | BTIG Research | Buy |
| 2020-06-19 | 재확인 | H.C. Wainwright | Buy |
| 2019-10-01 | 재개 | Craig Hallum | Buy |
| 2019-05-09 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2019-02-15 | 개시 | Jefferies | Buy |
| 2018-10-23 | 재개 | Raymond James | Strong Buy |
| 2018-09-18 | 재확인 | H.C. Wainwright | Neutral |
| 2017-11-27 | 개시 | H.C. Wainwright | Buy |
| 2016-06-14 | 재확인 | Mizuho | Buy |
| 2015-09-29 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2015-09-25 | 개시 | Craig Hallum | Buy |
| 2015-03-18 | 재확인 | Mizuho | Buy |
모두보기
Caredx Inc 주식(CDNA)의 최신 뉴스
CareDx (CDNA) Successfully Resolves Legal Action - GuruFocus
How Investors Are Reacting To CareDx (CDNA) Profit Return, Higher 2026 Outlook And New Shelf Registration - simplywall.st
CareDx(CDNA) Stock Options Chain | Quotes & News - Moomoo
CareDx Announces Dismissal of 2021 Qui Tam Suit - The Joplin Globe
Earnings Preview: CareDx to Report Financial Results Post-market on April 28 - Moomoo
Technical Reactions to CDNA Trends in Macro Strategies - Stock Traders Daily
Insider Sell: Jeffrey Novack Sells 2,688 Shares of CareDx Inc (C - GuruFocus
CareDx (NASDAQ: CDNA) counsel's 2,688-share sale under 10b5-1 - Stock Titan
CareDx (CDNA) Q1 2026 Earnings Call Transcript - AOL.com
[144] CareDx, Inc. SEC Filing - Stock Titan
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The National Law Review
A Look At CareDx (CDNA) Valuation After Recent Share Price Momentum Cools - Yahoo Finance
CareDx (CDNA) General Counsel has 2,873 shares withheld to cover RSU taxes - Stock Titan
How Investors Are Reacting To CareDx (CDNA) Profitability Milestone And Higher 2026 Revenue Guidance - Sahm
CareDx (NASDAQ:CDNA) Upgraded to Strong-Buy at Wall Street Zen - MarketBeat
MSN Money - MSN
23 new CareDx hires receive 63,856 stock units under Nasdaq rule - Stock Titan
CareDx sharpens focus on core testing services - MSN
CareDx (CDNA) Q2 2025 Earnings Transcript - AOL.com
CareDx : 2025 Annual Report - marketscreener.com
CareDx : 2026 Proxy Statement - marketscreener.com
CDNA SEC FilingsCaredx 10-K, 10-Q, 8-K Forms - Stock Titan
Analysts Conflicted on These Healthcare Names: CareDx (CDNA), Biogen (BIIB) and Guardant Health (GH) - The Globe and Mail
H.C. Wainwright reiterates Neutral rating on CareDx stock By Investing.com - Investing.com Australia
H.C. Wainwright reiterates Neutral rating on CareDx stock - Investing.com
Analysts Offer Insights on Healthcare Companies: Janux Therapeutics Inc (JANX), Stryker (SYK) and CareDx (CDNA) - The Globe and Mail
CareDx Acquires Navaris and Divests Lab Products to Accelerate Growth - HarianBasis.co
Analysts Offer Insights on Healthcare Companies: CareDx (CDNA) and Ultragenyx Pharmaceutical (RARE) - The Globe and Mail
CareDx Earnings Call: Growth Accelerates Amid Bold Pivot - TipRanks
CareDx Announces Agreement to Acquire Naveris, A Leader in Viral-Mediated Cancer MRD Surveillance Testing - The National Law Review
Q1 2026 Presentation (04/28/2026 00: 00 - marketscreener.com
CareDx (NASDAQ:CDNA) Trading Down 8.7%What's Next? - MarketBeat
CareDx sharpens precision medicine focus with $260m Naveris acquisition - Yahoo Finance
Caredx to acquire Naveris for up to $260 million - BioWorld News
CareDx : ESG Report (CareDx 2026 ESG Report) - marketscreener.com
CDNA Maintained by BTIG -- Price Target Raised to $28.00 - GuruFocus
CareDx to Acquire Oncology Diagnostics Company Naveris for $160 Million - Clinical Lab Products
CareDx, Inc Q1 2026 Earnings Call Summary - Yahoo Finance
CareDx (NASDAQ:CDNA) Price Target Raised to $28.00 at BTIG Research - MarketBeat
CareDx, Inc (NASDAQ:CDNA) Q1 2026 Earnings Call Transcript - Insider Monkey
BTIG raises CareDx stock price target on oncology diagnostics deal - Investing.com UK
BTIG raises CareDx stock price target on oncology diagnostics deal By Investing.com - Investing.com Nigeria
CareDx Inc (CDNA) Q1 2026 Earnings Call Highlights: Strong Reven - GuruFocus
CareDx (CDNA) Returns To Quarterly Profit Challenging Skepticism Around Its Earnings Story - Sahm
CareDx Announces First Quarter 2026 Financial Results - BioSpace
CareDx Q1 2026 Earnings Call Transcript - MarketBeat
CareDx to acquire Naveris for $160M up-front, $100M in revenue milestones - TipRanks
CareDx to acquire oncology diagnostics firm Naveris for $160M By Investing.com - Investing.com South Africa
CareDx (CDNA) Q1 2026: EPS $0.05 Beats -$0.03 Est; Revenue $118M - GuruFocus
CareDx to Acquire Naveris to Expand Into Cancer MRD Testing - Yahoo Finance
CDNA Adjusts 2026 EBITDA Forecast to $43M-$57M Range - GuruFocus
Caredx Inc (CDNA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.89%
0.56%
자본화:
|
볼륨(24시간):